AJ
Therapeutic Areas
Aeovian Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AV078 | Tuberous Sclerosis Complex (TSC) Refractory Epilepsy | Phase 1 |
Leadership Team at Aeovian Pharmaceuticals
JK
John Kincaid
Chief Scientific Officer
DC
Davis C. Ryman, MD, PhD
Chief Medical Officer
MZ
Micah Zajic
Chief Financial Officer